Home

Health Catalyst, Inc - Common stock (HCAT)

3.6500
-0.1000 (-2.67%)
NASDAQ · Last Trade: Jul 18th, 5:04 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close3.750
Open3.790
Bid3.640
Ask3.650
Day's Range3.610 - 3.790
52 Week Range3.490 - 9.240
Volume450,519
Market Cap170.10M
PE Ratio (TTM)-3.174
EPS (TTM)-1.2
Dividend & YieldN/A (N/A)
1 Month Average Volume566,623

Chart

About Health Catalyst, Inc - Common stock (HCAT)

Health Catalyst Inc is a leading provider of data and analytics technology for healthcare organizations, focused on improving clinical and financial outcomes through its innovative solutions. By leveraging a robust data platform, the company enables healthcare providers to aggregate, analyze, and visualize their data, facilitating better decision-making and operational efficiencies. Health Catalyst's suite of applications and services supports organizations in their journey towards value-based care by enhancing performance improvement initiatives, driving better patient outcomes, and optimizing healthcare delivery systems. Ultimately, the company's mission is to empower healthcare organizations with the insights and tools needed to transform the industry and enhance the quality of care. Read More

News & Press Releases

3 Unprofitable Stocks We Approach with Caution
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Via StockStory · July 18, 2025
Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025
SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
By Health Catalyst, Inc. · Via GlobeNewswire · July 17, 2025
3 Cash-Burning Stocks with Open Questions
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to significant downside.
Via StockStory · July 16, 2025
3 Russell 2000 Stocks in Hot Water
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Via StockStory · July 15, 2025
Earnings Scheduled For May 7, 2025benzinga.com
Via Benzinga · May 7, 2025
Deep Dive Into Health Catalyst Stock: Analyst Perspectives (5 Ratings)benzinga.com
Via Benzinga · July 9, 2025
Data Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers.
Via StockStory · June 16, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · June 12, 2025
HCAT Q1 Earnings Call: Ignite Platform Drives Client Growth Amid Funding Uncertainty
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.3% year on year to $79.41 million. On the other hand, next quarter’s revenue guidance of $80.5 million was less impressive, coming in 3.1% below analysts’ estimates. Its non-GAAP profit of $0.01 per share was in line with analysts’ consensus estimates.
Via StockStory · June 11, 2025
Health Catalyst, Steven Madden, Astronics, Wayfair, and Robinhood Shares Are Soaring, What You Need To Know
A number of stocks jumped in the pre-market session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. 
Via StockStory · May 27, 2025
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Question
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Via StockStory · May 26, 2025
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, May 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:
By Health Catalyst, Inc. · Via GlobeNewswire · May 20, 2025
3 Stocks Under $10 with Questionable Fundamentals
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
Via StockStory · May 20, 2025
1 Mooning Stock Worth Your Attention and 2 to Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Via StockStory · May 12, 2025
Breaking Down Health Catalyst: 9 Analysts Share Their Viewsbenzinga.com
Via Benzinga · May 8, 2025
Health Catalyst (NASDAQ:HCAT) Posts Q1 Sales In Line With Estimates, Stock Soars
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.3% year on year to $79.41 million. On the other hand, next quarter’s revenue guidance of $80.5 million was less impressive, coming in 3.1% below analysts’ estimates. Its non-GAAP profit of $0.01 per share was in line with analysts’ consensus estimates.
Via StockStory · May 7, 2025
Health Catalyst Reports First Quarter 2025 Results
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025.
By Health Catalyst, Inc. · Via GlobeNewswire · May 7, 2025
Health Catalyst (HCAT) Reports Earnings Tomorrow: What To Expect
Healthcare software provider Health Catalyst (NASDAQ:HCAT) will be reporting earnings tomorrow after the bell. Here’s what you need to know.
Via StockStory · May 6, 2025
Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · April 28, 2025
Q4 Earnings Outperformers: Health Catalyst (NASDAQ:HCAT) And The Rest Of The Data Analytics Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers.
Via StockStory · April 25, 2025
Cadence, DocuSign, Health Catalyst, UiPath, and Amplitude Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after stocks extended their rebound, led by strong gains in the technology sector, as renewed optimism surrounding U.S.–China trade negotiations lifted investor sentiment. 
Via StockStory · April 24, 2025
Pure Storage, Health Catalyst, AMD, Micron, and FormFactor Stocks Trade Up, What You Need To Know
A number of stocks jumped in the morning session after President Trump clarified that he had no intention of removing Federal Reserve Chair Jerome Powell, a statement that helped calm markets. Earlier remarks had sparked fears of political interference in decision making at the central bank. With Trump walking back his earlier comments, investors likely felt more assured that monetary policy decisions would continue to be guided by data, not drama. That kept the Fed's word credible, and more importantly, gave investors a steadier compass to figure out where rates and the markets were headed next. 
Via StockStory · April 23, 2025
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025
SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
By Health Catalyst, Inc. · Via GlobeNewswire · April 17, 2025
This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesdaybenzinga.com
Via Benzinga · April 9, 2025
Forecasting The Future: 10 Analyst Projections For Health Catalystbenzinga.com
Via Benzinga · April 9, 2025